P&G plans to cut 5,700 jobs
Procter & Gamble Co. plans to cut about 5,700 nonmanufacturing jobs by the end of its 2013 fiscal year next summer. P&G reported the workforce reduction plan Thursday on the day of its 2012 Analyst Meeting here.
Supplier News
Sanofi, Elizabeth Perkins make casting call for diabetes documentary
Actress Elizabeth Perkins has teamed up with Sanofi US on the "Diabetes Co-Stars" awareness campaign to produce a documentary that will feature people with diabetes and those who support them.
Rocasuba unveils homeopathic energy patch
Rocasuba Inc. has extended its product lineup with the debut of an all-natural energy patch. Rocasuba calls Spot On Energy a safer, healthier alternative to energy drinks, shots and pills.
Pharmacy college honors Kirby Lester CEO Zage
Kirby Lester president and chief executive officer Garry Zage, R.Ph., has been named 2012 Alumnus of the Year by the University of Illinois College of Pharmacy. Kirby Lester’s Garry Zage (left) with Illinois College of Pharmacy Dean Jerry Bauman.
LipiGesic M cited as ‘first-line therapy’ for migraines
PuraMed BioScience Inc. said its homeopathic remedy LipiGesic M has been recognized as an effective first-line therapy for acute migraine headaches.
Mylan, Watson cleared to market Revatio generics
Mylan Inc. and Watson Pharmaceuticals Inc. have received approval from the Food and Drug Administration for sildenafil citrate tablets (20 mg), a hypertension medication.
Pop band One Direction stars on new Colgate products
Colgate-Palmolive plans to feature pop band sensation One Direction on three new oral care products due out this month. The company said Tuesday that the U.K.
Topricin introduces trial size
Topical BioMedics is making its Topricin homeopathic pain relief and healing cream available in a new trial size. Homepathic topical pain reliever Topricin now comes in a new trial size.
Qualitest recalls lots of painkiller
Qualitest has voluntarily recalled 101 lots of hydrocodone bitartrate and acetaminophen tablets (10 mg/500 mg) because of the potential for oversized pills.
Zephrex-D decongestant formulated to prevent illicit use
Westport Pharmaceuticals has launched Zephrex-D, a tamper-resistant pseudoephedrine-based decongestant, at retail stores and pharmacies in the St. Louis area and throughout Missouri. The tablets feature tamper-resistant packaging.
Physicians Formula shareholders OK sale to Markwins
Shareholders of Physicians Formula Holdings Inc. have approved the company’s acquisition by Markwins International Corp. The companies said the $75 million acquisition deal, announced in late September, was given the green light Thursday at Physicians Formula’s stockholder meeting.
Becton Dickinson names Kozy as COO
William Kozy has been appointed chief operating officer at Becton, Dickinson & Co. (BD). The medical device, equipment and supplies company said Tuesday that Kozy adds the COO title to his current position of executive vice president.
Pfizer’s Xeljanz arthritis drug approved
Pfizer Inc. has been cleared by the Food and Drug Administration to market Xeljanz, a medication for rheumatoid arthritis. The company said Wednesday that Xeljanz (tofacitinib citrate) represents the first new oral disease-modifying antirheumatic drug for rheumatoid arthritis (RA) in over 10 years.
DJ duo NERVO becomes new CoverGirls
Electronic dance music DJ duo NERVO has been signed up as the newest CoverGirls. The Procter & Gamble makeup brand said the music stars, who are sisters, bring a "beauty with an edge" flair and make their public debut as CoverGirls on Wednesday "spinning in style" at a CoverGirl-sponsored event in
Boehringer Ingelheim recalls lot of Pradaxa
Boehringer Ingelheim Pharmaceuticals Inc. has initiated a nationwide voluntary recall of a single manufacturing lot of Pradaxa, an anticoagulant.
Perrigo names new board member
Perrigo Co. has appointed Jacqualyn Fouse, an executive at biopharmaceutical company Celgene Corp., as a director on its board.